187 related articles for article (PubMed ID: 15222120)
1. [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Yajima T; Furukawa Y; Ishii Y; Hattori Y; Matsumoto N; Yamamoto M; Yamaoka Y; Fujihara M; Fujita M; Kuniki H
Gan To Kagaku Ryoho; 2004 Jun; 31(6):953-7. PubMed ID: 15222120
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
Nakai Y; Isayama H; Kawabe T; Tsujino T; Yoshida H; Sasaki T; Tada M; Arizumi T; Yagioka H; Kogure H; Togawa O; Ito Y; Matsubara S; Hirano K; Sasahira N; Omata M
Pancreas; 2008 Nov; 37(4):405-10. PubMed ID: 18953253
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy.
Takasawa O; Fujita N; Kobayashi G; Noda Y; Ito K; Horaguchi J
World J Gastroenterol; 2006 Dec; 12(45):7299-303. PubMed ID: 17143944
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Sunagozaka H; Yamashita T; Kagaya T; Kato Y; Kaneko S
Gan To Kagaku Ryoho; 2006 Jun; 33(6):829-32. PubMed ID: 16770107
[TBL] [Abstract][Full Text] [Related]
5. [Locally advanced pancreatic cancer that enlarged after administration of gemcitabine and responded to oral TS-1--a case report].
Tanaka S; Fujii M; Goubaru M; Ohta T; Ogata M; Makino Y
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1485-7. PubMed ID: 16227755
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
Li Y; Sun J; Jiang Z; Zhang L; Liu G
J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
[TBL] [Abstract][Full Text] [Related]
7. [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
Sato Y; Tsuchiya Y; Aizawa M; Nomura T; Nashimoto A
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1151-4. PubMed ID: 25248901
[TBL] [Abstract][Full Text] [Related]
8. [A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
Sugimoto K; Okada K; Nakahira S; Okamura S; Miki H; Nakata K; Suzuki R; Yoshimura M; Uji K; Yoshida A; Tamura S
Gan To Kagaku Ryoho; 2009 Feb; 36(2):321-3. PubMed ID: 19223756
[TBL] [Abstract][Full Text] [Related]
9. [Unresectable Gallbladder Cancer Successfully Treated with Gemcitabine Chemotherapy].
Furukawa T; Takahashi H; Tanaka K; Muto T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1723-5. PubMed ID: 26805151
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Cao C; Kuang M; Xu W; Zhang X; Chen J; Tang C
Jpn J Clin Oncol; 2015 Dec; 45(12):1122-30. PubMed ID: 26518328
[TBL] [Abstract][Full Text] [Related]
11. [A long-term survivor case with good quality of life due to biliary bypass and gemcitabine for advanced pancreatic cancer].
Maeyama R; Fukuyama T; Morimatsu K; Tamura T; Ishikawa N; Hachiya Y; Sako T; Hirano Y
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1873-5. PubMed ID: 18030028
[TBL] [Abstract][Full Text] [Related]
12. Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients.
Matsumoto K; Miyake Y; Kato H; Kawamoto H; Imagawa A; Toyokawa T; Nakatsu M; Ando M; Hirohata M; Yamamoto K
Digestion; 2011; 84(3):230-5. PubMed ID: 21860243
[TBL] [Abstract][Full Text] [Related]
13. [Long-term survival of a patient with locally advanced unresectable pancreatic cancer treated with gemcitabine after chemoradiation therapy].
Chohno T; Aoki T; Hyuga S; Watanabe R; Matsumoto T; Takemoto H; Takachi K; Nishioka K; Uemura Y; Kobayashi K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1881-3. PubMed ID: 24393953
[TBL] [Abstract][Full Text] [Related]
14. [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
Hatata T; Takaya S; Taniguchi K; Naka T; Kondo A; Ikeguchi M
Gan To Kagaku Ryoho; 2011 Jan; 38(1):109-12. PubMed ID: 21368469
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.
Loehrer PJ; Feng Y; Cardenes H; Wagner L; Brell JM; Cella D; Flynn P; Ramanathan RK; Crane CH; Alberts SR; Benson AB
J Clin Oncol; 2011 Nov; 29(31):4105-12. PubMed ID: 21969502
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of gemcitabine therapy for recurrent or metastatic pancreatic cancer].
Moriwaki T; Hyodo I; Nishina T; Nasu J; Hidaka S; Kajiwara T; Tsuzuki T; Hirao K; Tsubouchi E; Yamauchi Y; Hirasaki S; Masumoto T; Tanada M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1373-6. PubMed ID: 15446559
[TBL] [Abstract][Full Text] [Related]
17. [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
Ishikawa T; Mizuno K; Watanabe K; Baba Y; Oota H; Yoshida T; Kamimura T
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1555-8. PubMed ID: 15508450
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
[TBL] [Abstract][Full Text] [Related]
20. [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
Suda H; Omori K; Suematsu Y; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Wakabayashi K; Ito Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2388-90. PubMed ID: 26805373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]